{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:34:34Z","timestamp":1790998474579,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sohag University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Bilastine (BIL) is a new second-generation antihistaminic drug used for the management of urticaria and rhino-conjunctivitis symptoms. Herein, a spectrofluorimetric method for determining BIL is described. The method is very sensitive, simple, quick, and green. The suggested method depended on the measurement of the original fluorescence of BIL in 1.0\u00a0M sulfuric acid at an emission wavelength of 385\u00a0nm after an excitation at 272\u00a0nm. The method was evaluated by the International Council on Harmonization (ICH) requirements. The relationship between BIL concentrations and the fluorescence intensities was linear in a range of 10.0\u2013500.0 ng mL<jats:sup>\u2212\u20091<\/jats:sup>, and the correlation coefficient was 0.9999. The detection limit was 2.9 ng mL<jats:sup>\u2212\u20091<\/jats:sup> and the quantitation limit was 8.8 ng mL<jats:sup>\u2212\u20091<\/jats:sup>. The suitable sensitivity and selectivity of the suggested method enabled its application successfully in analyzing BIL in pharmaceutical tablets without any interfering effect from their excipients and in spiked human plasma with appropriate recoveries from 95.72 to 97.24%. Additionally, the suggested method was utilized for content uniformity testing.<\/jats:p>","DOI":"10.1186\/s13065-025-01622-y","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T16:16:33Z","timestamp":1756656993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Validation of a green and sensitive spectrofluorimetric method for determination of Bilastine and its application to pharmaceutical preparations, content uniformity test, and spiked human plasma"],"prefix":"10.1186","volume":"19","author":[{"given":"Ahmed S.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid M.","family":"Badr El-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Khorshed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed M.","family":"Derayea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Oraby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"issue":"9","key":"1622_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2165\/11209310-000000000-00000","volume":"72","author":"NJ Carter","year":"2012","unstructured":"Carter NJ. Bilastine Drugs. 2012;72(9):1257\u201369.","journal-title":"Bilastine Drugs"},{"issue":"12","key":"1622_CR2","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s40261-016-0447-2","volume":"36","author":"M Togawa","year":"2016","unstructured":"Togawa M, Yamaya H, Rodr\u00edguez M, Nagashima H. Pharmacokinetics, pharmacodynamics and population pharmacokinetic\/pharmacodynamic modelling of bilastine, a second-generation antihistamine, in healthy Japanese subjects. Clin Drug Investig. 2016;36(12):1011\u201321.","journal-title":"Clin Drug Investig"},{"issue":"5","key":"1622_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s40261-013-0076-y","volume":"33","author":"B S\u00e1daba","year":"2013","unstructured":"S\u00e1daba B, G\u00f3mez-Guiu A, Azanza JR, Ortega I, Valiente R. Oral availability of Bilastine. Clin Drug Investig. 2013;33(5):375\u201381.","journal-title":"Clin Drug Investig"},{"key":"1622_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jpba.2016.04.022","volume":"125","author":"J Terzi\u0107","year":"2016","unstructured":"Terzi\u0107 J, Popovi\u0107 I, Staji\u0107 A, Tumpa A, Jan\u010di\u0107-Stojanovi\u0107 B. Application of analytical quality by design concept for Bilastine and its degradation impurities determination by hydrophilic interaction liquid chromatographic method. J Pharm Biomed Anal. 2016;125:385\u201393.","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"1622_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.22456\/2527-2616.79221","volume":"1","author":"AT Da Silva","year":"2017","unstructured":"Da Silva AT, Brabo GR, Marques ID, Bajerski L, Malesuik MD, Paim CS. UV spectrophotometric method for quantitative determination of Bilastine using experimental design for robustness. Drug Anal Res. 2017;1(2):38\u201343.","journal-title":"Drug Anal Res"},{"key":"1622_CR6","unstructured":"Raj RM, Sankar ASK. Analytical method development and validation for simultaneous Estimation of Bilastine and Montelukast sodium by Uv spectrophotometry. World J Pharm Pharm Sci. 2021;10(1)."},{"issue":"2","key":"1622_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.5958\/0974-360X.2020.00176.6","volume":"13","author":"P Prathyusha","year":"2020","unstructured":"Prathyusha P, Sundararajan R. UV spectrophotometric method for determination of Bilastine in bulk and pharmaceutical formulation. Res J Pharm Technol. 2020;13(2):933\u20138.","journal-title":"Res J Pharm Technol"},{"key":"1622_CR8","doi-asserted-by":"publisher","first-page":"121246","DOI":"10.1016\/j.saa.2022.121246","volume":"276","author":"AS Radwan","year":"2022","unstructured":"Radwan AS, Elkhoudary MM, Hadad GM, Belal F, Salim MM. A highly sensitive spectrofluorimetric method for the determination of Bilastine in its pharmaceutical preparations and biological fluids. Spectrochim Acta Part A Mol Biomol Spectrosc. 2022;276:121246.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"issue":"4","key":"1622_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s11696-019-00956-x","volume":"74","author":"R Ouarezki","year":"2020","unstructured":"Ouarezki R, Guermouche S, Guermouche M-H. Degradation kinetics of Bilastine determined by RP-HPLC method and identification of its degradation product in oxidative condition. Chem Pap. 2020;74(4):1133\u201342.","journal-title":"Chem Pap"},{"issue":"5\u2013S","key":"1622_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.22270\/jddt.v11i5-S.5086","volume":"11","author":"KR Gupta","year":"2021","unstructured":"Gupta KR, Tembhare EP, Ganorkar AV, Karemore H, Umekar MJ. Stability and degradation kinetic study of Bilastine in solution state by RP-HPLC method. J Drug Deliv Ther. 2021;11(5\u2013S):48\u201356.","journal-title":"J Drug Deliv Ther"},{"issue":"6","key":"1622_CR11","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/jaoacint\/qsaa059","volume":"103","author":"PR Motta","year":"2020","unstructured":"Motta PR, dos Santos Porto D, Martini PRR, Bajerski L, Azeredo JB, Paula FR, et al. Bilastine: quantitative determination by LC with fluorescence detection and structural Elucidation of the degradation products using HRMS. J AOAC Int. 2020;103(6):1451\u201360. https:\/\/doi.org\/10.1093\/jaoacint\/qsaa059.","journal-title":"J AOAC Int"},{"issue":"1","key":"1622_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0378-4347(01)00267-5","volume":"760","author":"LA Berrueta","year":"2001","unstructured":"Berrueta LA, Fernandez-Armentia M, Bakkali A, Gonzalo A, Lucero ML, Orjales A. Matrix solid-phase dispersion technique for the determination of a new antiallergic drug, bilastine, in rat faeces. J Chromatogr B Biomed Appl. 2001;760(1):185\u201390.","journal-title":"J Chromatogr B Biomed Appl"},{"issue":"4","key":"1622_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00764-021-00120-w","volume":"34","author":"DA Shah","year":"2021","unstructured":"Shah DA, Patel PA, Chhalotiya U. Thin-layer chromatographic\u2013densitometric method of analysis for the Estimation of Montelukast and Bilastine in combination. JPC-J PLANAR CHROMAT. 2021;34(4):289\u201395. https:\/\/doi.org\/10.1007\/s00764-021-00120-w.","journal-title":"JPC-J PLANAR CHROMAT"},{"key":"1622_CR14","doi-asserted-by":"publisher","first-page":"114277","DOI":"10.1016\/j.jpba.2021.114277","volume":"204","author":"D Biagi","year":"2021","unstructured":"Biagi D, Nencioni P, Valleri M, Calamassi N, Mura P. Development of a near infrared spectroscopy method for the in-line quantitative Bilastine drug determination during pharmaceutical powders blending. J Pharm Biomed Anal. 2021;204:114277. https:\/\/doi.org\/10.1016\/j.jpba.2021.114277.","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"1622_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/elan.202060494","volume":"33","author":"JG Teixeira","year":"2021","unstructured":"Teixeira JG, Oliveira J. Voltammetric study of the antihistamine drug bilastine: anodic characterization and quantification using a reusable MWCNTs modified screen printed carbon electrode. Electroanalysis. 2021;33(4):891\u20139.","journal-title":"Electroanalysis"},{"issue":"2","key":"1622_CR16","first-page":"167","volume":"65","author":"K Badr El-Din","year":"2022","unstructured":"Badr El-Din K, Ahmed A, Khorshed A, Derayea S, Oraby M. Smart spectrophotometric methods based on feasible mathematical processing and classical chemometry for the simultaneous assay of alcaftadine and ketorolac in their recently approved pharmaceutical formulation. Egypt J Chem. 2022;65(2):167\u201374.","journal-title":"Egypt J Chem"},{"issue":"1","key":"1622_CR17","doi-asserted-by":"publisher","first-page":"10615","DOI":"10.1038\/s41598-025-92183-6","volume":"15","author":"SM Derayea","year":"2025","unstructured":"Derayea SM, Badr El-Din KM, Ahmed AS, Oraby M, Abdelshakour MA. Green HPLC-Fluorescence detection method for concurrent analysis of Tamsulosin hydrochloride and Tolterodine tartrate in dosage forms and biological fluids. Sci Rep. 2025;15(1):10615.","journal-title":"Sci Rep"},{"issue":"1","key":"1622_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13065-024-01116-3","volume":"18","author":"SM Derayea","year":"2024","unstructured":"Derayea SM, Badr El-Din KM, Ahmed AS, Khorshed AA, Oraby M. Development of a green synchronous spectrofluorimetric technique for simultaneous determination of Montelukast sodium and Bilastine in pharmaceutical formulations. BMC Chem. 2024;18(1):18.","journal-title":"BMC Chem"},{"key":"1622_CR19","doi-asserted-by":"crossref","unstructured":"Weitner T, Friganovi\u0107 T, \u0160aki\u0107 D. Inner Filter Effect Correction for Fluorescence Measurements in Microplates Using Variable Vertical Axis Focus. Analytical Chemistry. 2022.","DOI":"10.1021\/acs.analchem.2c01031"},{"issue":"7","key":"1622_CR20","doi-asserted-by":"publisher","first-page":"e103878","DOI":"10.1371\/journal.pone.0103878","volume":"9","author":"AV Fonin","year":"2014","unstructured":"Fonin AV, Sulatskaya AI, Kuznetsova IM, Turoverov KK. Fluorescence of dyes in solutions with high absorbance. Inner filter effect correction. PLoS ONE. 2014;9(7):e103878.","journal-title":"PLoS ONE"},{"key":"1622_CR21","doi-asserted-by":"publisher","first-page":"106329","DOI":"10.1016\/j.microc.2021.106329","volume":"167","author":"M Oraby","year":"2021","unstructured":"Oraby M, Ahmed AS, Abdel-Lateef MA, Mostafa MAH, Hassan AI. Employ FTIR spectroscopic method for determination of certain multiple sclerosis medications in plasma and pharmaceutical formulations. Microchem J. 2021;167:106329\u201335. https:\/\/doi.org\/10.1016\/j.microc.2021.106329.","journal-title":"Microchem J"},{"issue":"1","key":"1622_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13065-024-01137-y","volume":"18","author":"SM Derayea","year":"2024","unstructured":"Derayea SM, Badr El-din KM, Ahmed AS, Khorshed AA, Oraby M. Determination of antihistaminic drugs alcaftadine and Olopatadine hydrochloride via ion-pairing with Eosin Y as a spectrofluorimetric and spectrophotometric probe: application to dosage forms. BMC Chem. 2024;18(1):40.","journal-title":"BMC Chem"},{"key":"1622_CR23","unstructured":"ICH: Q2 (R1.): Validation of analytical procedures: text and methodology. In: International Conference on Harmonization, Geneva. 2005."},{"key":"1622_CR24","unstructured":"Pesez MB, Pesez. J Bartos Clin Biochem Anal. 1974."},{"key":"1622_CR25","unstructured":"Rockville M. The united States pharmacopoeia 30, the National formulary 25 US pharmacopeial convention. Electron Version. 2007:2287\u20138."},{"key":"1622_CR26","doi-asserted-by":"publisher","first-page":"123986","DOI":"10.1016\/j.saa.2024.123986","volume":"311","author":"SM Derayea","year":"2024","unstructured":"Derayea SM, El-Din KMB, Ahmed AS, Abdelshakour MA, Oraby M. An eco-friendly one-pot spectrofluorimetric approach for the facile determination of overactive bladder drug, tolterodine: application to dosage forms and biological fluids. Spectrochimica Acta Part A: Mol Biomol Spectrosc. 2024;311:123986.","journal-title":"Spectrochimica Acta Part A: Mol Biomol Spectrosc"},{"key":"1622_CR27","doi-asserted-by":"crossref","unstructured":"Valeur B, Berberan-Santos MN. Molecular fluorescence: principles and applications. Wiley; 2013.","DOI":"10.1002\/9783527650002"},{"key":"1622_CR28","doi-asserted-by":"crossref","unstructured":"Lakowicz JR. Principles of fluorescence spectroscopy. Springer; 2006.","DOI":"10.1007\/978-0-387-46312-4"},{"issue":"6","key":"1622_CR29","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s10895-015-1656-4","volume":"25","author":"ME El-Kommos","year":"2015","unstructured":"El-Kommos ME, El-Gizawy SM, Atia NN, Hosny NM. Determination of some non-sedating antihistamines via their native fluorescence and derivation of some quantitative fluorescence intensity-structure relationships. J Fluoresc. 2015;25(6):1695\u2013709.","journal-title":"J Fluoresc"},{"key":"1622_CR30","doi-asserted-by":"publisher","first-page":"124515","DOI":"10.1016\/j.saa.2024.124515","volume":"318","author":"SM Derayea","year":"2024","unstructured":"Derayea SM, Ahmed AS, Abdelshakour MA, Oraby M, El-Din KMB. Diaryl pyrrolone fluorescent probing strategy for mirabegron determination through condensation with ninhydrin and phenylacetaldehyde: application to dosage forms, human urine and plasma. Spectrochimica Acta Part A: Mol Biomol Spectrosc. 2024;318:124515.","journal-title":"Spectrochimica Acta Part A: Mol Biomol Spectrosc"},{"issue":"8","key":"1622_CR31","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1039\/b926439f","volume":"39","author":"M Tobiszewski","year":"2010","unstructured":"Tobiszewski M, Mechli\u0144ska A, Namie\u015bnik J. Green analytical chemistry\u2014theory and practice. Chem Soc Rev. 2010;39(8):2869\u201378.","journal-title":"Chem Soc Rev"},{"issue":"1","key":"1622_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13065-025-01411-7","volume":"19","author":"KM Badr El-Din","year":"2025","unstructured":"Badr El-Din KM, Derayea SM, Ahmed AS, Oraby M, Abdelshakour MA. Two birds with one stone: sustainable smart spectrophotometric methods for concurrent determination of silodosin and mirabegron: application to dosage forms and greenness assessment. BMC Chem. 2025;19(1):56.","journal-title":"BMC Chem"},{"key":"1622_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","volume":"37","author":"A Ga\u0142uszka","year":"2012","unstructured":"Ga\u0142uszka A, Migaszewski ZM, Konieczka P, Namie\u015bnik J. Analytical Eco-Scale for assessing the greenness of analytical procedures. TRAC Trends Anal Chem. 2012;37:61\u201372.","journal-title":"TRAC Trends Anal Chem"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01622-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01622-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01622-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:05:30Z","timestamp":1757484330000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01622-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1622"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01622-y","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,31]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no human subjects in this research and informed consent is not applicable. The used plasma is pooled plasma from the blood bank of Sohag university hospital. All experimental protocols in the current study were approved by the Committee of Research Ethics in the Faculty of Pharmacy, Sohag University, Sohag, Egypt. All described procedures were carried out in accordance with relevant regulations and guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"258"}}